These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17596115)

  • 1. Racial differences in switching, augmentation, and titration of lipid-lowering agents by Medicare/Medicaid dual-eligible patients.
    Mark TL; Axelsen KJ; Mucha L; Sadkova Y
    Am J Manag Care; 2007 Jun; 13 Suppl 3():S72-9. PubMed ID: 17596115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in use of lipid-lowering medications among black and white dual enrollees with diabetes transitioning from Medicaid to Medicare Part D drug coverage.
    Adams AS; Madden JM; Zhang F; Soumerai SB; Gilden D; Griggs J; Trinacty CM; Bishop C; Ross-Degnan D
    Med Care; 2014 Aug; 52(8):695-703. PubMed ID: 24988304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparities in lipid management for African Americans and Caucasians with coronary artery disease: a national cross-sectional study.
    Massing MW; Foley KA; Carter-Edwards L; Sueta CA; Alexander CM; Simpson RJ
    BMC Cardiovasc Disord; 2004 Aug; 4():15. PubMed ID: 15317654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Transitioning to Medicare Part D on Access to Drugs for Medical Conditions among Dual Enrollees with Cancer.
    Adams AS; Madden JM; Zhang F; Lu CY; Ross-Degnan D; Lee A; Soumerai SB; Gilden D; Chawla N; Griggs JJ
    Value Health; 2017 Dec; 20(10):1345-1354. PubMed ID: 29241894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in the Use of Nonstatin Lipid-Lowering Therapy Among Patients With Coronary Heart Disease: A Retrospective Cohort Study in the Medicare Population 2007 to 2011.
    Bittner V; Deng L; Rosenson RS; Taylor B; Glasser SP; Kent ST; Farkouh ME; Muntner P
    J Am Coll Cardiol; 2015 Oct; 66(17):1864-72. PubMed ID: 26493657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of prior authorization on the use and costs of lipid-lowering medications among Michigan and Indiana dual enrollees in Medicaid and Medicare: results of a longitudinal, population-based study.
    Lu CY; Law MR; Soumerai SB; Graves AJ; LeCates RF; Zhang F; Ross-Degnan D; Adams AS
    Clin Ther; 2011 Jan; 33(1):135-44. PubMed ID: 21397779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial differences in medication compliance and healthcare utilization among hypertensive Medicaid recipients: fixed-dose vs free-combination treatment.
    Dickson M; Plauschinat CA
    Ethn Dis; 2008; 18(2):204-9. PubMed ID: 18507275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial disparity in psychotropic medications prescribed for youths with Medicaid insurance in Maryland.
    Zito JM; Safer DJ; dosReis S; Riddle MA
    J Am Acad Child Adolesc Psychiatry; 1998 Feb; 37(2):179-84. PubMed ID: 9473914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial disparities in lipid control in patients with diabetes.
    Saffar D; Williams K; Lafata JE; Divine G; Pladevall M
    Am J Manag Care; 2012 Jun; 18(6):303-11. PubMed ID: 22774998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overprescribing of lipid lowering agents.
    Smith MA; Cox ED; Bartell JM
    Qual Saf Health Care; 2006 Aug; 15(4):251-7. PubMed ID: 16885249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geographic Variation and Disparities in Total Joint Replacement Use for Medicare Beneficiaries: 2009 to 2017.
    Thirukumaran CP; Cai X; Glance LG; Kim Y; Ricciardi BF; Fiscella KA; Li Y
    J Bone Joint Surg Am; 2020 Dec; 102(24):2120-2128. PubMed ID: 33079898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia.
    Li P; McElligott S; Bergquist H; Schwartz JS; Doshi JA
    Ann Intern Med; 2012 Jun; 156(11):776-84, W-263, W-264, W-265, W-266, W-267, W-268, W-269. PubMed ID: 22665815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial differences in lipid-lowering agent use in medicaid patients with cardiovascular disease.
    Litaker D; Koroukian SM
    Med Care; 2004 Oct; 42(10):1009-18. PubMed ID: 15377934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current lipid management and low cholesterol goal attainment in common daily practice in Spain. The REALITY Study.
    García Ruiz FJ; Marín Ibáñez A; Pérez-Jiménez F; Pintó X; Nocea G; Ahumada C; Alemao E; Yin D;
    Pharmacoeconomics; 2004; 22 Suppl 3():1-12. PubMed ID: 15669149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Race/ethnicity and nonadherence to prescription medications among seniors: results of a national study.
    Gellad WF; Haas JS; Safran DG
    J Gen Intern Med; 2007 Nov; 22(11):1572-8. PubMed ID: 17882499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring racial and ethnic disparities in prescription drug spending and use among Medicare beneficiaries.
    Gaskin DJ; Briesacher BA; Limcangco R; Brigantti BL
    Am J Geriatr Pharmacother; 2006 Jun; 4(2):96-111. PubMed ID: 16860257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agreement between Medicare pharmacy claims, self-report, and medication inventory for assessing lipid-lowering medication use.
    Colantonio LD; Kent ST; Kilgore ML; Delzell E; Curtis JR; Howard G; Safford MM; Muntner P
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):827-35. PubMed ID: 26823152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial and Ethnic Differences in Minimally Adequate Depression Care Among Medicaid-Enrolled Youth.
    Cummings JR; Ji X; Lally C; Druss BG
    J Am Acad Child Adolesc Psychiatry; 2019 Jan; 58(1):128-138. PubMed ID: 30577928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial differences in medication adherence: A cross-sectional study of Medicare enrollees.
    Gerber BS; Cho YI; Arozullah AM; Lee SY
    Am J Geriatr Pharmacother; 2010 Apr; 8(2):136-45. PubMed ID: 20439063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status.
    Bristow RE; Powell MA; Al-Hammadi N; Chen L; Miller JP; Roland PY; Mutch DG; Cliby WA
    J Natl Cancer Inst; 2013 Jun; 105(11):823-32. PubMed ID: 23539755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.